Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-048913)

Filing Details

Accession Number:: 0001209191-19-048913
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-09 16:52:41
Reporting Period:: 2019-09-06

Accepted Time:: 2019-09-09 16:52:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1262104	Mei Pharma Inc.	MEIP	Pharmaceutical Preparations (2834)	510407811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1371859	Anna Christine White	C/O Mei Pharma, Inc. 3611 Valley Centre Drive, Suite 500 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-09-06	15,000	$1.74	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares purchased by the reporting person are held through an Individual Retirement Account.
The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.